nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—CYP2D6—Carteolol—glaucoma	0.0784	0.104	CbGbCtD
Amprenavir—CYP2D6—Betaxolol—glaucoma	0.0529	0.0705	CbGbCtD
Amprenavir—CYP2C19—Methazolamide—glaucoma	0.0528	0.0703	CbGbCtD
Amprenavir—CYP2C9—Diclofenamide—glaucoma	0.051	0.0679	CbGbCtD
Amprenavir—CYP2C9—Dorzolamide—glaucoma	0.0492	0.0656	CbGbCtD
Amprenavir—CYP3A5—Clonidine—glaucoma	0.0473	0.063	CbGbCtD
Amprenavir—CYP2C19—Timolol—glaucoma	0.0449	0.0598	CbGbCtD
Amprenavir—CYP2C9—Methazolamide—glaucoma	0.0439	0.0584	CbGbCtD
Amprenavir—CYP2D6—Methazolamide—glaucoma	0.0401	0.0534	CbGbCtD
Amprenavir—CYP3A4—Pilocarpine—glaucoma	0.0378	0.0503	CbGbCtD
Amprenavir—ABCB1—Timolol—glaucoma	0.0362	0.0482	CbGbCtD
Amprenavir—CYP2D6—Timolol—glaucoma	0.0341	0.0454	CbGbCtD
Amprenavir—ABCB1—Clonidine—glaucoma	0.0308	0.041	CbGbCtD
Amprenavir—CYP3A4—Brinzolamide—glaucoma	0.0296	0.0395	CbGbCtD
Amprenavir—CYP2D6—Clonidine—glaucoma	0.029	0.0386	CbGbCtD
Amprenavir—CYP3A4—Dorzolamide—glaucoma	0.0286	0.0381	CbGbCtD
Amprenavir—CYP3A4—Methazolamide—glaucoma	0.0255	0.034	CbGbCtD
Amprenavir—CYP3A4—Acetazolamide—glaucoma	0.0204	0.0272	CbGbCtD
Amprenavir—CYP3A4—Clonidine—glaucoma	0.0184	0.0246	CbGbCtD
Amprenavir—Cardiac disorder—Travoprost—glaucoma	0.00082	0.00336	CcSEcCtD
Amprenavir—Mental disorder—Brimonidine—glaucoma	0.000814	0.00333	CcSEcCtD
Amprenavir—Cardiac disorder—Brinzolamide—glaucoma	0.000809	0.00332	CcSEcCtD
Amprenavir—Myalgia—Apraclonidine—glaucoma	0.000802	0.00328	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000796	0.00326	CcSEcCtD
Amprenavir—Discomfort—Apraclonidine—glaucoma	0.000792	0.00325	CcSEcCtD
Amprenavir—Asthenia—Carteolol—glaucoma	0.000787	0.00323	CcSEcCtD
Amprenavir—Asthenia—Diclofenamide—glaucoma	0.000774	0.00317	CcSEcCtD
Amprenavir—Mental disorder—Travoprost—glaucoma	0.000774	0.00317	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000772	0.00316	CcSEcCtD
Amprenavir—Mental disorder—Brinzolamide—glaucoma	0.000764	0.00313	CcSEcCtD
Amprenavir—Pruritus—Diclofenamide—glaucoma	0.000763	0.00313	CcSEcCtD
Amprenavir—Malnutrition—Brinzolamide—glaucoma	0.000759	0.00311	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.000758	0.00311	CcSEcCtD
Amprenavir—Nervous system disorder—Apraclonidine—glaucoma	0.000754	0.00309	CcSEcCtD
Amprenavir—Flatulence—Brinzolamide—glaucoma	0.000748	0.00306	CcSEcCtD
Amprenavir—Rash—Metipranolol—glaucoma	0.000747	0.00306	CcSEcCtD
Amprenavir—Skin disorder—Apraclonidine—glaucoma	0.000746	0.00306	CcSEcCtD
Amprenavir—Dermatitis—Metipranolol—glaucoma	0.000746	0.00306	CcSEcCtD
Amprenavir—Asthenia—Levobunolol—glaucoma	0.000744	0.00305	CcSEcCtD
Amprenavir—Depression—Clonidine—glaucoma	0.000743	0.00305	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Betaxolol—glaucoma	0.000743	0.00304	CcSEcCtD
Amprenavir—Headache—Metipranolol—glaucoma	0.000742	0.00304	CcSEcCtD
Amprenavir—Pruritus—Levobunolol—glaucoma	0.000733	0.00301	CcSEcCtD
Amprenavir—Nervous system disorder—Bimatoprost—glaucoma	0.000731	0.00299	CcSEcCtD
Amprenavir—Skin disorder—Bimatoprost—glaucoma	0.000724	0.00297	CcSEcCtD
Amprenavir—Diarrhoea—Carbachol—glaucoma	0.00072	0.00295	CcSEcCtD
Amprenavir—Flatulence—Pilocarpine—glaucoma	0.000719	0.00295	CcSEcCtD
Amprenavir—Asthenia—Methazolamide—glaucoma	0.000713	0.00292	CcSEcCtD
Amprenavir—Tremor—Brinzolamide—glaucoma	0.000711	0.00291	CcSEcCtD
Amprenavir—Diarrhoea—Levobunolol—glaucoma	0.000709	0.00291	CcSEcCtD
Amprenavir—Discomfort—Acetazolamide—glaucoma	0.000708	0.0029	CcSEcCtD
Amprenavir—Angioedema—Dorzolamide—glaucoma	0.000705	0.00289	CcSEcCtD
Amprenavir—Nausea—Metipranolol—glaucoma	0.000703	0.00288	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.0007	0.00287	CcSEcCtD
Amprenavir—Paraesthesia—Apraclonidine—glaucoma	0.00069	0.00283	CcSEcCtD
Amprenavir—Myalgia—Brimonidine—glaucoma	0.000688	0.00282	CcSEcCtD
Amprenavir—Headache—Carteolol—glaucoma	0.000687	0.00282	CcSEcCtD
Amprenavir—Vomiting—Diclofenamide—glaucoma	0.000686	0.00281	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000683	0.0028	CcSEcCtD
Amprenavir—Tremor—Pilocarpine—glaucoma	0.000683	0.0028	CcSEcCtD
Amprenavir—Pruritus—Latanoprost—glaucoma	0.00068	0.00279	CcSEcCtD
Amprenavir—Rash—Diclofenamide—glaucoma	0.00068	0.00279	CcSEcCtD
Amprenavir—Discomfort—Brimonidine—glaucoma	0.00068	0.00279	CcSEcCtD
Amprenavir—Diarrhoea—Methazolamide—glaucoma	0.000679	0.00278	CcSEcCtD
Amprenavir—Headache—Diclofenamide—glaucoma	0.000676	0.00277	CcSEcCtD
Amprenavir—Vomiting—Carbachol—glaucoma	0.000669	0.00274	CcSEcCtD
Amprenavir—Rash—Carbachol—glaucoma	0.000664	0.00272	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000663	0.00272	CcSEcCtD
Amprenavir—Dermatitis—Carbachol—glaucoma	0.000663	0.00272	CcSEcCtD
Amprenavir—Fatigue—Apraclonidine—glaucoma	0.000663	0.00271	CcSEcCtD
Amprenavir—Headache—Carbachol—glaucoma	0.000659	0.0027	CcSEcCtD
Amprenavir—Hyperglycaemia—Betaxolol—glaucoma	0.000657	0.00269	CcSEcCtD
Amprenavir—Myalgia—Travoprost—glaucoma	0.000654	0.00268	CcSEcCtD
Amprenavir—Nausea—Carteolol—glaucoma	0.000652	0.00267	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00065	0.00266	CcSEcCtD
Amprenavir—Headache—Levobunolol—glaucoma	0.000649	0.00266	CcSEcCtD
Amprenavir—Discomfort—Dorzolamide—glaucoma	0.000649	0.00266	CcSEcCtD
Amprenavir—Depression—Betaxolol—glaucoma	0.000647	0.00265	CcSEcCtD
Amprenavir—Nervous system disorder—Brimonidine—glaucoma	0.000647	0.00265	CcSEcCtD
Amprenavir—Discomfort—Travoprost—glaucoma	0.000647	0.00265	CcSEcCtD
Amprenavir—Myalgia—Brinzolamide—glaucoma	0.000646	0.00265	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000643	0.00264	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000642	0.00263	CcSEcCtD
Amprenavir—Skin disorder—Brimonidine—glaucoma	0.000641	0.00263	CcSEcCtD
Amprenavir—Nausea—Diclofenamide—glaucoma	0.000641	0.00262	CcSEcCtD
Amprenavir—Acute coronary syndrome—Betaxolol—glaucoma	0.00064	0.00262	CcSEcCtD
Amprenavir—Discomfort—Brinzolamide—glaucoma	0.000638	0.00262	CcSEcCtD
Amprenavir—Myocardial infarction—Betaxolol—glaucoma	0.000636	0.00261	CcSEcCtD
Amprenavir—Liver function test abnormal—Timolol—glaucoma	0.000635	0.0026	CcSEcCtD
Amprenavir—Vomiting—Methazolamide—glaucoma	0.000631	0.00259	CcSEcCtD
Amprenavir—Gastrointestinal pain—Apraclonidine—glaucoma	0.000628	0.00257	CcSEcCtD
Amprenavir—Rash—Methazolamide—glaucoma	0.000626	0.00257	CcSEcCtD
Amprenavir—Dermatitis—Methazolamide—glaucoma	0.000626	0.00256	CcSEcCtD
Amprenavir—Nausea—Carbachol—glaucoma	0.000625	0.00256	CcSEcCtD
Amprenavir—Headache—Methazolamide—glaucoma	0.000622	0.00255	CcSEcCtD
Amprenavir—Cardiac disorder—Clonidine—glaucoma	0.000621	0.00254	CcSEcCtD
Amprenavir—Myalgia—Pilocarpine—glaucoma	0.000621	0.00254	CcSEcCtD
Amprenavir—Paraesthesia—Acetazolamide—glaucoma	0.000617	0.00253	CcSEcCtD
Amprenavir—Nausea—Levobunolol—glaucoma	0.000616	0.00252	CcSEcCtD
Amprenavir—Nervous system disorder—Travoprost—glaucoma	0.000615	0.00252	CcSEcCtD
Amprenavir—Discomfort—Pilocarpine—glaucoma	0.000614	0.00251	CcSEcCtD
Amprenavir—Skin disorder—Travoprost—glaucoma	0.000609	0.0025	CcSEcCtD
Amprenavir—Abdominal pain—Apraclonidine—glaucoma	0.000608	0.00249	CcSEcCtD
Amprenavir—Nervous system disorder—Brinzolamide—glaucoma	0.000607	0.00249	CcSEcCtD
Amprenavir—Rash—Latanoprost—glaucoma	0.000606	0.00248	CcSEcCtD
Amprenavir—Dermatitis—Latanoprost—glaucoma	0.000606	0.00248	CcSEcCtD
Amprenavir—Headache—Latanoprost—glaucoma	0.000602	0.00247	CcSEcCtD
Amprenavir—Skin disorder—Brinzolamide—glaucoma	0.000602	0.00247	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000601	0.00246	CcSEcCtD
Amprenavir—Anorexia—Dorzolamide—glaucoma	0.000601	0.00246	CcSEcCtD
Amprenavir—Decreased appetite—Acetazolamide—glaucoma	0.000598	0.00245	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000593	0.00243	CcSEcCtD
Amprenavir—Fatigue—Acetazolamide—glaucoma	0.000593	0.00243	CcSEcCtD
Amprenavir—Paraesthesia—Brimonidine—glaucoma	0.000592	0.00243	CcSEcCtD
Amprenavir—Nausea—Methazolamide—glaucoma	0.00059	0.00242	CcSEcCtD
Amprenavir—Mental disorder—Clonidine—glaucoma	0.000586	0.0024	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000574	0.00235	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Travoprost—glaucoma	0.000572	0.00234	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Brimonidine—glaucoma	0.00057	0.00233	CcSEcCtD
Amprenavir—Fatigue—Brimonidine—glaucoma	0.000569	0.00233	CcSEcCtD
Amprenavir—Anorexia—Pilocarpine—glaucoma	0.000568	0.00233	CcSEcCtD
Amprenavir—Paraesthesia—Dorzolamide—glaucoma	0.000566	0.00232	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000564	0.00231	CcSEcCtD
Amprenavir—Paraesthesia—Brinzolamide—glaucoma	0.000556	0.00228	CcSEcCtD
Amprenavir—Asthenia—Apraclonidine—glaucoma	0.000551	0.00226	CcSEcCtD
Amprenavir—Decreased appetite—Dorzolamide—glaucoma	0.000548	0.00224	CcSEcCtD
Amprenavir—Tremor—Clonidine—glaucoma	0.000546	0.00224	CcSEcCtD
Amprenavir—Pruritus—Apraclonidine—glaucoma	0.000544	0.00223	CcSEcCtD
Amprenavir—Fatigue—Dorzolamide—glaucoma	0.000543	0.00223	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000542	0.00222	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Travoprost—glaucoma	0.000542	0.00222	CcSEcCtD
Amprenavir—Fatigue—Travoprost—glaucoma	0.000541	0.00222	CcSEcCtD
Amprenavir—Cardiac disorder—Betaxolol—glaucoma	0.000541	0.00222	CcSEcCtD
Amprenavir—Decreased appetite—Brinzolamide—glaucoma	0.000538	0.00221	CcSEcCtD
Amprenavir—Hyperglycaemia—Timolol—glaucoma	0.000536	0.0022	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000535	0.00219	CcSEcCtD
Amprenavir—Paraesthesia—Pilocarpine—glaucoma	0.000535	0.00219	CcSEcCtD
Amprenavir—Asthenia—Bimatoprost—glaucoma	0.000535	0.00219	CcSEcCtD
Amprenavir—Fatigue—Brinzolamide—glaucoma	0.000534	0.00219	CcSEcCtD
Amprenavir—Angioedema—Clonidine—glaucoma	0.000532	0.00218	CcSEcCtD
Amprenavir—Depression—Timolol—glaucoma	0.000529	0.00217	CcSEcCtD
Amprenavir—Pruritus—Bimatoprost—glaucoma	0.000527	0.00216	CcSEcCtD
Amprenavir—Diarrhoea—Apraclonidine—glaucoma	0.000526	0.00215	CcSEcCtD
Amprenavir—Decreased appetite—Pilocarpine—glaucoma	0.000518	0.00212	CcSEcCtD
Amprenavir—Gastrointestinal pain—Dorzolamide—glaucoma	0.000515	0.00211	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000514	0.00211	CcSEcCtD
Amprenavir—Gastrointestinal pain—Travoprost—glaucoma	0.000513	0.0021	CcSEcCtD
Amprenavir—Mental disorder—Betaxolol—glaucoma	0.00051	0.00209	CcSEcCtD
Amprenavir—Malnutrition—Betaxolol—glaucoma	0.000507	0.00208	CcSEcCtD
Amprenavir—Abdominal pain—Dorzolamide—glaucoma	0.000498	0.00204	CcSEcCtD
Amprenavir—Abdominal pain—Travoprost—glaucoma	0.000496	0.00203	CcSEcCtD
Amprenavir—Asthenia—Acetazolamide—glaucoma	0.000493	0.00202	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000493	0.00202	CcSEcCtD
Amprenavir—Discomfort—Clonidine—glaucoma	0.00049	0.00201	CcSEcCtD
Amprenavir—Vomiting—Apraclonidine—glaucoma	0.000489	0.002	CcSEcCtD
Amprenavir—Gastrointestinal pain—Pilocarpine—glaucoma	0.000487	0.00199	CcSEcCtD
Amprenavir—Dermatitis—Apraclonidine—glaucoma	0.000484	0.00198	CcSEcCtD
Amprenavir—Headache—Apraclonidine—glaucoma	0.000481	0.00197	CcSEcCtD
Amprenavir—Tremor—Betaxolol—glaucoma	0.000475	0.00195	CcSEcCtD
Amprenavir—Asthenia—Brimonidine—glaucoma	0.000473	0.00194	CcSEcCtD
Amprenavir—Abdominal pain—Pilocarpine—glaucoma	0.000471	0.00193	CcSEcCtD
Amprenavir—Diarrhoea—Acetazolamide—glaucoma	0.00047	0.00193	CcSEcCtD
Amprenavir—Rash—Bimatoprost—glaucoma	0.00047	0.00192	CcSEcCtD
Amprenavir—Dermatitis—Bimatoprost—glaucoma	0.000469	0.00192	CcSEcCtD
Amprenavir—Connective tissue disorder—Timolol—glaucoma	0.000468	0.00192	CcSEcCtD
Amprenavir—Pruritus—Brimonidine—glaucoma	0.000467	0.00191	CcSEcCtD
Amprenavir—Headache—Bimatoprost—glaucoma	0.000467	0.00191	CcSEcCtD
Amprenavir—Nervous system disorder—Clonidine—glaucoma	0.000466	0.00191	CcSEcCtD
Amprenavir—Skin disorder—Clonidine—glaucoma	0.000462	0.00189	CcSEcCtD
Amprenavir—Nausea—Apraclonidine—glaucoma	0.000456	0.00187	CcSEcCtD
Amprenavir—Anorexia—Clonidine—glaucoma	0.000453	0.00186	CcSEcCtD
Amprenavir—Asthenia—Dorzolamide—glaucoma	0.000452	0.00185	CcSEcCtD
Amprenavir—Asthenia—Travoprost—glaucoma	0.00045	0.00184	CcSEcCtD
Amprenavir—Pruritus—Dorzolamide—glaucoma	0.000446	0.00183	CcSEcCtD
Amprenavir—Asthenia—Brinzolamide—glaucoma	0.000444	0.00182	CcSEcCtD
Amprenavir—Pruritus—Travoprost—glaucoma	0.000444	0.00182	CcSEcCtD
Amprenavir—Nausea—Bimatoprost—glaucoma	0.000443	0.00181	CcSEcCtD
Amprenavir—Cardiac disorder—Timolol—glaucoma	0.000442	0.00181	CcSEcCtD
Amprenavir—Pruritus—Brinzolamide—glaucoma	0.000438	0.0018	CcSEcCtD
Amprenavir—Vomiting—Acetazolamide—glaucoma	0.000437	0.00179	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Clonidine—glaucoma	0.000433	0.00177	CcSEcCtD
Amprenavir—Myalgia—Betaxolol—glaucoma	0.000432	0.00177	CcSEcCtD
Amprenavir—Diarrhoea—Dorzolamide—glaucoma	0.000431	0.00177	CcSEcCtD
Amprenavir—Headache—Acetazolamide—glaucoma	0.000431	0.00176	CcSEcCtD
Amprenavir—Diarrhoea—Travoprost—glaucoma	0.000429	0.00176	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000429	0.00176	CcSEcCtD
Amprenavir—Asthenia—Pilocarpine—glaucoma	0.000427	0.00175	CcSEcCtD
Amprenavir—Paraesthesia—Clonidine—glaucoma	0.000427	0.00175	CcSEcCtD
Amprenavir—Discomfort—Betaxolol—glaucoma	0.000427	0.00175	CcSEcCtD
Amprenavir—Diarrhoea—Brinzolamide—glaucoma	0.000424	0.00174	CcSEcCtD
Amprenavir—Pruritus—Pilocarpine—glaucoma	0.000421	0.00173	CcSEcCtD
Amprenavir—Mental disorder—Timolol—glaucoma	0.000417	0.00171	CcSEcCtD
Amprenavir—Rash—Brimonidine—glaucoma	0.000416	0.0017	CcSEcCtD
Amprenavir—Dermatitis—Brimonidine—glaucoma	0.000416	0.0017	CcSEcCtD
Amprenavir—Malnutrition—Timolol—glaucoma	0.000414	0.0017	CcSEcCtD
Amprenavir—Headache—Brimonidine—glaucoma	0.000413	0.00169	CcSEcCtD
Amprenavir—Decreased appetite—Clonidine—glaucoma	0.000413	0.00169	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Clonidine—glaucoma	0.00041	0.00168	CcSEcCtD
Amprenavir—Fatigue—Clonidine—glaucoma	0.00041	0.00168	CcSEcCtD
Amprenavir—Nausea—Acetazolamide—glaucoma	0.000408	0.00167	CcSEcCtD
Amprenavir—Diarrhoea—Pilocarpine—glaucoma	0.000407	0.00167	CcSEcCtD
Amprenavir—Nervous system disorder—Betaxolol—glaucoma	0.000406	0.00166	CcSEcCtD
Amprenavir—Skin disorder—Betaxolol—glaucoma	0.000402	0.00165	CcSEcCtD
Amprenavir—Vomiting—Dorzolamide—glaucoma	0.000401	0.00164	CcSEcCtD
Amprenavir—Rash—Dorzolamide—glaucoma	0.000397	0.00163	CcSEcCtD
Amprenavir—Dermatitis—Dorzolamide—glaucoma	0.000397	0.00163	CcSEcCtD
Amprenavir—Rash—Travoprost—glaucoma	0.000396	0.00162	CcSEcCtD
Amprenavir—Dermatitis—Travoprost—glaucoma	0.000395	0.00162	CcSEcCtD
Amprenavir—Headache—Dorzolamide—glaucoma	0.000395	0.00162	CcSEcCtD
Amprenavir—Anorexia—Betaxolol—glaucoma	0.000395	0.00162	CcSEcCtD
Amprenavir—Vomiting—Brinzolamide—glaucoma	0.000394	0.00161	CcSEcCtD
Amprenavir—Headache—Travoprost—glaucoma	0.000393	0.00161	CcSEcCtD
Amprenavir—Nausea—Brimonidine—glaucoma	0.000392	0.00161	CcSEcCtD
Amprenavir—Rash—Brinzolamide—glaucoma	0.000391	0.0016	CcSEcCtD
Amprenavir—Dermatitis—Brinzolamide—glaucoma	0.00039	0.0016	CcSEcCtD
Amprenavir—Gastrointestinal pain—Clonidine—glaucoma	0.000389	0.00159	CcSEcCtD
Amprenavir—Headache—Brinzolamide—glaucoma	0.000388	0.00159	CcSEcCtD
Amprenavir—Angioedema—Timolol—glaucoma	0.000379	0.00155	CcSEcCtD
Amprenavir—Vomiting—Pilocarpine—glaucoma	0.000379	0.00155	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000377	0.00155	CcSEcCtD
Amprenavir—Abdominal pain—Clonidine—glaucoma	0.000376	0.00154	CcSEcCtD
Amprenavir—Rash—Pilocarpine—glaucoma	0.000375	0.00154	CcSEcCtD
Amprenavir—Dermatitis—Pilocarpine—glaucoma	0.000375	0.00154	CcSEcCtD
Amprenavir—Nausea—Dorzolamide—glaucoma	0.000374	0.00153	CcSEcCtD
Amprenavir—Headache—Pilocarpine—glaucoma	0.000373	0.00153	CcSEcCtD
Amprenavir—Nausea—Travoprost—glaucoma	0.000373	0.00153	CcSEcCtD
Amprenavir—Paraesthesia—Betaxolol—glaucoma	0.000372	0.00152	CcSEcCtD
Amprenavir—Nausea—Brinzolamide—glaucoma	0.000368	0.00151	CcSEcCtD
Amprenavir—Decreased appetite—Betaxolol—glaucoma	0.00036	0.00147	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Betaxolol—glaucoma	0.000357	0.00146	CcSEcCtD
Amprenavir—Fatigue—Betaxolol—glaucoma	0.000357	0.00146	CcSEcCtD
Amprenavir—Nausea—Pilocarpine—glaucoma	0.000354	0.00145	CcSEcCtD
Amprenavir—Myalgia—Timolol—glaucoma	0.000353	0.00145	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00035	0.00144	CcSEcCtD
Amprenavir—Discomfort—Timolol—glaucoma	0.000349	0.00143	CcSEcCtD
Amprenavir—Asthenia—Clonidine—glaucoma	0.000341	0.0014	CcSEcCtD
Amprenavir—Pruritus—Clonidine—glaucoma	0.000336	0.00138	CcSEcCtD
Amprenavir—Nervous system disorder—Timolol—glaucoma	0.000332	0.00136	CcSEcCtD
Amprenavir—Skin disorder—Timolol—glaucoma	0.000328	0.00135	CcSEcCtD
Amprenavir—Diarrhoea—Clonidine—glaucoma	0.000325	0.00133	CcSEcCtD
Amprenavir—Anorexia—Timolol—glaucoma	0.000322	0.00132	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Timolol—glaucoma	0.000308	0.00126	CcSEcCtD
Amprenavir—Paraesthesia—Timolol—glaucoma	0.000304	0.00124	CcSEcCtD
Amprenavir—Vomiting—Clonidine—glaucoma	0.000302	0.00124	CcSEcCtD
Amprenavir—Rash—Clonidine—glaucoma	0.0003	0.00123	CcSEcCtD
Amprenavir—Dermatitis—Clonidine—glaucoma	0.0003	0.00123	CcSEcCtD
Amprenavir—Headache—Clonidine—glaucoma	0.000298	0.00122	CcSEcCtD
Amprenavir—Asthenia—Betaxolol—glaucoma	0.000297	0.00122	CcSEcCtD
Amprenavir—Decreased appetite—Timolol—glaucoma	0.000294	0.0012	CcSEcCtD
Amprenavir—Pruritus—Betaxolol—glaucoma	0.000293	0.0012	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Timolol—glaucoma	0.000292	0.0012	CcSEcCtD
Amprenavir—Fatigue—Timolol—glaucoma	0.000292	0.00119	CcSEcCtD
Amprenavir—Diarrhoea—Betaxolol—glaucoma	0.000283	0.00116	CcSEcCtD
Amprenavir—Nausea—Clonidine—glaucoma	0.000282	0.00116	CcSEcCtD
Amprenavir—Gastrointestinal pain—Timolol—glaucoma	0.000277	0.00113	CcSEcCtD
Amprenavir—Abdominal pain—Timolol—glaucoma	0.000267	0.0011	CcSEcCtD
Amprenavir—Vomiting—Betaxolol—glaucoma	0.000263	0.00108	CcSEcCtD
Amprenavir—Rash—Betaxolol—glaucoma	0.000261	0.00107	CcSEcCtD
Amprenavir—Dermatitis—Betaxolol—glaucoma	0.000261	0.00107	CcSEcCtD
Amprenavir—Headache—Betaxolol—glaucoma	0.000259	0.00106	CcSEcCtD
Amprenavir—Nausea—Betaxolol—glaucoma	0.000246	0.00101	CcSEcCtD
Amprenavir—Asthenia—Timolol—glaucoma	0.000243	0.000994	CcSEcCtD
Amprenavir—Pruritus—Timolol—glaucoma	0.000239	0.00098	CcSEcCtD
Amprenavir—Diarrhoea—Timolol—glaucoma	0.000231	0.000948	CcSEcCtD
Amprenavir—Vomiting—Timolol—glaucoma	0.000215	0.000881	CcSEcCtD
Amprenavir—Rash—Timolol—glaucoma	0.000213	0.000874	CcSEcCtD
Amprenavir—Dermatitis—Timolol—glaucoma	0.000213	0.000873	CcSEcCtD
Amprenavir—Headache—Timolol—glaucoma	0.000212	0.000868	CcSEcCtD
Amprenavir—Nausea—Timolol—glaucoma	0.000201	0.000823	CcSEcCtD
Amprenavir—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.75e-05	0.0056	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—SLC4A4—glaucoma	2.65e-05	0.00541	CbGpPWpGaD
Amprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	2.64e-05	0.00537	CbGpPWpGaD
Amprenavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.56e-05	0.00522	CbGpPWpGaD
Amprenavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.54e-05	0.00517	CbGpPWpGaD
Amprenavir—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.53e-05	0.00515	CbGpPWpGaD
Amprenavir—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.53e-05	0.00515	CbGpPWpGaD
Amprenavir—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.51e-05	0.0051	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.3e-05	0.00468	CbGpPWpGaD
Amprenavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.26e-05	0.0046	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CA5A—glaucoma	2.16e-05	0.00441	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—NARFL—glaucoma	2.16e-05	0.00441	CbGpPWpGaD
Amprenavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.08e-05	0.00423	CbGpPWpGaD
Amprenavir—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	2.07e-05	0.00422	CbGpPWpGaD
Amprenavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.06e-05	0.00419	CbGpPWpGaD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	2.04e-05	0.00415	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—GSTT1—glaucoma	1.99e-05	0.00406	CbGpPWpGaD
Amprenavir—ABCC1—Disease—LRP12—glaucoma	1.96e-05	0.00399	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—GSTT1—glaucoma	1.95e-05	0.00397	CbGpPWpGaD
Amprenavir—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	1.91e-05	0.0039	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	1.87e-05	0.00381	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.77e-05	0.00361	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—IL1A—glaucoma	1.75e-05	0.00357	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—GSTT1—glaucoma	1.69e-05	0.00343	CbGpPWpGaD
Amprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.67e-05	0.00341	CbGpPWpGaD
Amprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.65e-05	0.00337	CbGpPWpGaD
Amprenavir—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	1.63e-05	0.00331	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—CYP1B1—glaucoma	1.59e-05	0.00323	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	1.57e-05	0.00319	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—FAS—glaucoma	1.56e-05	0.00318	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—CYP1B1—glaucoma	1.55e-05	0.00316	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—C3—glaucoma	1.54e-05	0.00314	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	1.53e-05	0.00312	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—GSTT1—glaucoma	1.51e-05	0.00307	CbGpPWpGaD
Amprenavir—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	1.45e-05	0.00296	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NARFL—glaucoma	1.4e-05	0.00284	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CA5A—glaucoma	1.4e-05	0.00284	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—GSTT1—glaucoma	1.38e-05	0.00282	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—GSTT1—glaucoma	1.37e-05	0.0028	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NARFL—glaucoma	1.36e-05	0.00278	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CA5A—glaucoma	1.36e-05	0.00278	CbGpPWpGaD
Amprenavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	1.36e-05	0.00278	CbGpPWpGaD
Amprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.36e-05	0.00277	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—CYP1B1—glaucoma	1.34e-05	0.00274	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	1.33e-05	0.0027	CbGpPWpGaD
Amprenavir—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	1.32e-05	0.0027	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	1.32e-05	0.00269	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.3e-05	0.00264	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—GSTM1—glaucoma	1.27e-05	0.00258	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	1.26e-05	0.00257	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HEYL—glaucoma	1.26e-05	0.00257	CbGpPWpGaD
Amprenavir—ABCC1—Disease—FGFR1OP—glaucoma	1.26e-05	0.00257	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.26e-05	0.00256	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	1.25e-05	0.00255	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—GSTM1—glaucoma	1.24e-05	0.00253	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	1.22e-05	0.00249	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—CYP1B1—glaucoma	1.2e-05	0.00244	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	1.18e-05	0.00241	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NARFL—glaucoma	1.18e-05	0.00241	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CA5A—glaucoma	1.18e-05	0.00241	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.12e-05	0.00228	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—CYP1B1—glaucoma	1.1e-05	0.00225	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—CYP1B1—glaucoma	1.09e-05	0.00223	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	1.09e-05	0.00222	CbGpPWpGaD
Amprenavir—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	1.08e-05	0.0022	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—GSTM1—glaucoma	1.07e-05	0.00219	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	1.06e-05	0.00216	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CA1—glaucoma	1.06e-05	0.00215	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NARFL—glaucoma	1.06e-05	0.00215	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CA5A—glaucoma	1.06e-05	0.00215	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CA5A—glaucoma	1.03e-05	0.0021	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NARFL—glaucoma	1.03e-05	0.0021	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CTSA—glaucoma	1.02e-05	0.00208	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.02e-05	0.00208	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	9.85e-06	0.00201	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NARFL—glaucoma	9.7e-06	0.00198	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CA5A—glaucoma	9.7e-06	0.00198	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CA2—glaucoma	9.67e-06	0.00197	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CA5A—glaucoma	9.62e-06	0.00196	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NARFL—glaucoma	9.62e-06	0.00196	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—GSTM1—glaucoma	9.59e-06	0.00195	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	9.46e-06	0.00193	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.45e-06	0.00192	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.45e-06	0.00192	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	9.07e-06	0.00185	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—GSTT1—glaucoma	9.05e-06	0.00184	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	9.02e-06	0.00184	CbGpPWpGaD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	8.94e-06	0.00182	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—GSTM1—glaucoma	8.82e-06	0.0018	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—GSTM1—glaucoma	8.74e-06	0.00178	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	8.7e-06	0.00177	CbGpPWpGaD
Amprenavir—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	8.62e-06	0.00176	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	8.43e-06	0.00172	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HDAC9—glaucoma	7.88e-06	0.0016	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—VEGFA—glaucoma	7.74e-06	0.00158	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	7.72e-06	0.00157	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—CYP1B1—glaucoma	7.21e-06	0.00147	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	7.11e-06	0.00145	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CA1—glaucoma	6.82e-06	0.00139	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—TXN—glaucoma	6.81e-06	0.00139	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CA1—glaucoma	6.66e-06	0.00136	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—TNF—glaucoma	6.64e-06	0.00135	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CTSA—glaucoma	6.6e-06	0.00134	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.6e-06	0.00134	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CTSA—glaucoma	6.45e-06	0.00131	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NARFL—glaucoma	6.34e-06	0.00129	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CA5A—glaucoma	6.34e-06	0.00129	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CA2—glaucoma	6.24e-06	0.00127	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.22e-06	0.00127	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	6.17e-06	0.00126	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.16e-06	0.00125	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CA2—glaucoma	6.1e-06	0.00124	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CA1—glaucoma	5.77e-06	0.00118	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.77e-06	0.00117	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	5.69e-06	0.00116	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CTSA—glaucoma	5.59e-06	0.00114	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTT1—glaucoma	5.28e-06	0.00108	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CA2—glaucoma	5.28e-06	0.00108	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.16e-06	0.00105	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.16e-06	0.00105	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CA1—glaucoma	5.15e-06	0.00105	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CA1—glaucoma	5.03e-06	0.00102	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CTSA—glaucoma	4.99e-06	0.00102	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CTSA—glaucoma	4.87e-06	0.000992	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.85e-06	0.000988	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CA1—glaucoma	4.74e-06	0.000965	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CA2—glaucoma	4.71e-06	0.00096	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CA1—glaucoma	4.7e-06	0.000957	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.61e-06	0.000938	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.61e-06	0.000938	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CA2—glaucoma	4.6e-06	0.000937	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.6e-06	0.000936	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CTSA—glaucoma	4.59e-06	0.000935	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CTSA—glaucoma	4.55e-06	0.000927	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—TXN—glaucoma	4.39e-06	0.000895	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CA2—glaucoma	4.33e-06	0.000883	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CA2—glaucoma	4.3e-06	0.000875	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—TXN—glaucoma	4.29e-06	0.000875	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.26e-06	0.000867	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN2B—glaucoma	4.24e-06	0.000863	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP1B1—glaucoma	4.21e-06	0.000857	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ABCA1—glaucoma	4.21e-06	0.000857	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.2e-06	0.000855	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.2e-06	0.000855	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.82e-06	0.000778	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—TXN—glaucoma	3.72e-06	0.000758	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MTHFR—glaucoma	3.55e-06	0.000723	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTT1—glaucoma	3.41e-06	0.000694	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.39e-06	0.000691	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTM1—glaucoma	3.36e-06	0.000685	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.36e-06	0.000685	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTT1—glaucoma	3.33e-06	0.000678	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—TXN—glaucoma	3.32e-06	0.000676	CbGpPWpGaD
Amprenavir—ABCC1—Disease—APOE—glaucoma	3.31e-06	0.000673	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.28e-06	0.000667	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CAV1—glaucoma	3.27e-06	0.000667	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—TXN—glaucoma	3.24e-06	0.00066	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CA1—glaucoma	3.1e-06	0.000631	CbGpPWpGaD
Amprenavir—ABCC1—Disease—BAD—glaucoma	3.08e-06	0.000627	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—TXN—glaucoma	3.05e-06	0.000622	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.03e-06	0.000617	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—TXN—glaucoma	3.03e-06	0.000617	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3e-06	0.000611	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CTSA—glaucoma	3e-06	0.000611	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—MTHFR—glaucoma	2.97e-06	0.000606	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.89e-06	0.000588	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTT1—glaucoma	2.88e-06	0.000587	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CA2—glaucoma	2.83e-06	0.000577	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—APOE—glaucoma	2.77e-06	0.000564	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.76e-06	0.000563	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CAV1—glaucoma	2.74e-06	0.000559	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.74e-06	0.000557	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ABCA1—glaucoma	2.71e-06	0.000553	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP1B1—glaucoma	2.71e-06	0.000553	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP1B1—glaucoma	2.65e-06	0.00054	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ABCA1—glaucoma	2.65e-06	0.00054	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTT1—glaucoma	2.57e-06	0.000524	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTT1—glaucoma	2.51e-06	0.000512	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOS3—glaucoma	2.48e-06	0.000504	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTT1—glaucoma	2.37e-06	0.000482	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTT1—glaucoma	2.35e-06	0.000478	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.33e-06	0.000474	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ABCA1—glaucoma	2.3e-06	0.000468	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP1B1—glaucoma	2.3e-06	0.000468	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTGS2—glaucoma	2.26e-06	0.000461	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTM1—glaucoma	2.17e-06	0.000442	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN1B—glaucoma	2.15e-06	0.000437	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTM1—glaucoma	2.12e-06	0.000432	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.08e-06	0.000423	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—NOS3—glaucoma	2.07e-06	0.000422	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ABCA1—glaucoma	2.05e-06	0.000418	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP1B1—glaucoma	2.05e-06	0.000418	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP1B1—glaucoma	2e-06	0.000408	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ABCA1—glaucoma	2e-06	0.000408	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TXN—glaucoma	2e-06	0.000407	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—MTHFR—glaucoma	1.92e-06	0.000391	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—glaucoma	1.9e-06	0.000386	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.89e-06	0.000385	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP1B1—glaucoma	1.89e-06	0.000384	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ABCA1—glaucoma	1.89e-06	0.000384	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—MTHFR—glaucoma	1.87e-06	0.000382	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ABCA1—glaucoma	1.87e-06	0.000381	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP1B1—glaucoma	1.87e-06	0.000381	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTM1—glaucoma	1.84e-06	0.000374	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—APOE—glaucoma	1.79e-06	0.000364	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CAV1—glaucoma	1.77e-06	0.00036	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—APOE—glaucoma	1.75e-06	0.000355	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CAV1—glaucoma	1.73e-06	0.000352	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTM1—glaucoma	1.64e-06	0.000334	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—MTHFR—glaucoma	1.62e-06	0.000331	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTM1—glaucoma	1.6e-06	0.000326	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTT1—glaucoma	1.55e-06	0.000315	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—APOE—glaucoma	1.51e-06	0.000308	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTM1—glaucoma	1.51e-06	0.000307	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CAV1—glaucoma	1.5e-06	0.000305	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTM1—glaucoma	1.5e-06	0.000305	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—MTHFR—glaucoma	1.45e-06	0.000295	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—MTHFR—glaucoma	1.41e-06	0.000288	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—APOE—glaucoma	1.35e-06	0.000275	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NOS3—glaucoma	1.34e-06	0.000272	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CAV1—glaucoma	1.34e-06	0.000272	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—MTHFR—glaucoma	1.33e-06	0.000271	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—MTHFR—glaucoma	1.32e-06	0.000269	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—APOE—glaucoma	1.32e-06	0.000268	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NOS3—glaucoma	1.31e-06	0.000266	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CAV1—glaucoma	1.3e-06	0.000266	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—APOE—glaucoma	1.24e-06	0.000253	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCA1—glaucoma	1.23e-06	0.000251	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP1B1—glaucoma	1.23e-06	0.000251	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—APOE—glaucoma	1.23e-06	0.000251	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CAV1—glaucoma	1.23e-06	0.00025	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—glaucoma	1.22e-06	0.000249	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CAV1—glaucoma	1.22e-06	0.000248	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—glaucoma	1.2e-06	0.000244	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NOS3—glaucoma	1.13e-06	0.000231	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—glaucoma	1.04e-06	0.000211	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NOS3—glaucoma	1.01e-06	0.000206	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NOS3—glaucoma	9.87e-07	0.000201	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTM1—glaucoma	9.86e-07	0.000201	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NOS3—glaucoma	9.3e-07	0.000189	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—glaucoma	9.24e-07	0.000188	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NOS3—glaucoma	9.22e-07	0.000188	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—glaucoma	9.02e-07	0.000184	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTHFR—glaucoma	8.71e-07	0.000177	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—glaucoma	8.5e-07	0.000173	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—glaucoma	8.43e-07	0.000172	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOE—glaucoma	8.11e-07	0.000165	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CAV1—glaucoma	8.04e-07	0.000164	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NOS3—glaucoma	6.08e-07	0.000124	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—glaucoma	5.56e-07	0.000113	CbGpPWpGaD
